Page last updated: 2024-11-03

pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid and Benign Neoplasms, Brain

pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid has been researched along with Benign Neoplasms, Brain in 2 studies

pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid: a novel antagonist that selectively blocks P2 purinoceptor receptors; a useful tool to study co-transmission in tissues when ATP and coexisting neurotransmitters act in concert
5'-phosphopyridoxal-6-azobenzene-2,4-disulfonic acid : An arenesulfonic acid that is pyridoxal 5'-phosphate carrying an additional 2,4-disulfophenylazo substituent at position 6.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, BC1
Lee, CM1
Lin, WW1
Sabala, P1
Czajkowski, R1
Przybyłek, K1
Kalita, K1
Kaczmarek, L1
Barańska, J1

Other Studies

2 other studies available for pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid and Benign Neoplasms, Brain

ArticleYear
Inhibition of ecto-ATPase by PPADS, suramin and reactive blue in endothelial cells, C6 glioma cells and RAW 264.7 macrophages.
    British journal of pharmacology, 1996, Volume: 119, Issue:8

    Topics: Adenosine Triphosphatases; Animals; Brain Neoplasms; Cell Line; Endothelium, Vascular; Enzyme Inhibi

1996
Two subtypes of G protein-coupled nucleotide receptors, P2Y(1) and P2Y(2) are involved in calcium signalling in glioma C6 cells.
    British journal of pharmacology, 2001, Volume: 132, Issue:2

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Brain Neoplasms; Calcium; Calcium Signaling;

2001